Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Net Income: 2020-2024

Historic Net Income for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to -$140.0 million.

  • Arcutis Biotherapeutics' Net Income rose 117.84% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 77.33%. This contributed to the annual value of -$140.0 million for FY2024, which is 46.58% up from last year.
  • As of FY2024, Arcutis Biotherapeutics' Net Income stood at -$140.0 million, which was up 46.58% from -$262.1 million recorded in FY2023.
  • Arcutis Biotherapeutics' 5-year Net Income high stood at -$136.6 million for FY2020, and its period low was -$311.5 million during FY2022.
  • For the 3-year period, Arcutis Biotherapeutics' Net Income averaged around -$237.9 million, with its median value being -$262.1 million (2023).
  • Its Net Income has fluctuated over the past 5 years, first crashed by 51.02% in 2021, then skyrocketed by 46.58% in 2024.
  • Yearly analysis of 5 years shows Arcutis Biotherapeutics' Net Income stood at -$136.6 million in 2020, then tumbled by 51.02% to -$206.4 million in 2021, then crashed by 50.93% to -$311.5 million in 2022, then climbed by 15.83% to -$262.1 million in 2023, then soared by 46.58% to -$140.0 million in 2024.